Journal article
Emerging infectious diseases, 2005
Chair in Molecular Virology
01634 202957
Medway School of Pharmacy,
Anson Building,
Central Avenue,
Chatham Maritime,
Kent, ME4 4TB
United Kingdom
APA
Click to copy
Temperton, N., Chan, P., Simmons, G., Zambon, M., Tedder, R., Takeuchi, Y., & Weiss, R. (2005). Longitudinally Profiling Neutralizing Antibody Response to SARS Coronavirus with Pseudotypes. Emerging Infectious Diseases.
Chicago/Turabian
Click to copy
Temperton, N., P. Chan, G. Simmons, M. Zambon, R. Tedder, Y. Takeuchi, and R. Weiss. “Longitudinally Profiling Neutralizing Antibody Response to SARS Coronavirus with Pseudotypes.” Emerging infectious diseases (2005).
MLA
Click to copy
Temperton, N., et al. “Longitudinally Profiling Neutralizing Antibody Response to SARS Coronavirus with Pseudotypes.” Emerging Infectious Diseases, 2005.
BibTeX Click to copy
@article{n2005a,
title = {Longitudinally Profiling Neutralizing Antibody Response to SARS Coronavirus with Pseudotypes},
year = {2005},
journal = {Emerging infectious diseases},
author = {Temperton, N. and Chan, P. and Simmons, G. and Zambon, M. and Tedder, R. and Takeuchi, Y. and Weiss, R.}
}
SARS-CoV spike protein pseudotypes are the basis of an in vitro microneutralization assay sensitive and specific for SARS-CoV neutralizing antibodies.